Suppr超能文献

人肝酶制剂在体外对7-酮石胆酸的还原作用。

Reduction of 7-ketolithocholic acid by human liver enzyme preparations in vitro.

作者信息

Amuro Y, Yamade W, Kudo K, Yamamoto T, Hada T, Higashino K

机构信息

Third Department of Internal Medicine, Hyogo College of Medicine, Japan.

出版信息

Am J Physiol. 1989 Jan;256(1 Pt 1):G67-71. doi: 10.1152/ajpgi.1989.256.1.G67.

Abstract

The formation of chenodeoxycholic and ursodeoxycholic acids from 7-ketolithocholic acid by human liver preparations was examined in vitro. Liver preparations were incubated with 7-ketolithocholic acid at pH 5.5 in a sodium-potassium-phosphate buffer containing NADPH or NADH. The products formed were analyzed by gas chromatography and gas chromatography-mass spectrometry. Results showed that chenodeoxycholic and ursodeoxycholic acids could be formed from 7-ketolithocholic acid by human liver enzyme(s). The enzyme(s) required NADPH but not NADH as coenzyme and was localized largely in the microsomes. The conjugated 7-ketolithocholic acid, especially the taurine conjugated, was predominantly reduced to chenodeoxycholic acid, whereas the unconjugated 7-ketolithocholic acid was not reduced well to either chenodeoxycholic acid or ursodeoxycholic acid. Thus the reduction of 7-ketolithocholic acid by human liver enzyme(s) was found to be dependent on whether the substrate was conjugated or not.

摘要

在体外研究了人肝脏制剂将7-酮石胆酸转化为鹅去氧胆酸和熊去氧胆酸的过程。将肝脏制剂与7-酮石胆酸在含有NADPH或NADH的磷酸钠钾缓冲液中于pH 5.5下孵育。通过气相色谱和气相色谱-质谱法分析形成的产物。结果表明,人肝脏酶可将7-酮石胆酸转化为鹅去氧胆酸和熊去氧胆酸。该酶需要NADPH而非NADH作为辅酶,且主要定位于微粒体中。结合型7-酮石胆酸,尤其是牛磺酸结合型,主要还原为鹅去氧胆酸,而未结合型7-酮石胆酸还原为鹅去氧胆酸或熊去氧胆酸的效果不佳。因此发现人肝脏酶对7-酮石胆酸的还原取决于底物是否结合。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验